IL229658A0 - Scylo-inositol for the treatment of behavioral and psychiatric disorders - Google Patents
Scylo-inositol for the treatment of behavioral and psychiatric disordersInfo
- Publication number
- IL229658A0 IL229658A0 IL229658A IL22965813A IL229658A0 IL 229658 A0 IL229658 A0 IL 229658A0 IL 229658 A IL229658 A IL 229658A IL 22965813 A IL22965813 A IL 22965813A IL 229658 A0 IL229658 A0 IL 229658A0
- Authority
- IL
- Israel
- Prior art keywords
- scyllo
- inositol
- behavioral
- treatment
- psychiatric disorders
- Prior art date
Links
- 230000003542 behavioural effect Effects 0.000 title 1
- 208000020016 psychiatric disease Diseases 0.000 title 1
- CDAISMWEOUEBRE-CDRYSYESSA-N scyllo-inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O CDAISMWEOUEBRE-CDRYSYESSA-N 0.000 title 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Anesthesiology (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161520031P | 2011-06-03 | 2011-06-03 | |
| US201161541333P | 2011-09-30 | 2011-09-30 | |
| US201261618680P | 2012-03-31 | 2012-03-31 | |
| PCT/US2012/040789 WO2012173808A1 (en) | 2011-06-03 | 2012-06-04 | Scyllo-inositol for the treatment of behavioral and psychiatric disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL229658A0 true IL229658A0 (en) | 2014-01-30 |
Family
ID=46298680
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL229658A IL229658A0 (en) | 2011-06-03 | 2013-11-27 | Scylo-inositol for the treatment of behavioral and psychiatric disorders |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20140243422A1 (OSRAM) |
| EP (1) | EP2714050A1 (OSRAM) |
| JP (1) | JP2014515408A (OSRAM) |
| KR (1) | KR20140041670A (OSRAM) |
| CN (1) | CN103906520A (OSRAM) |
| AU (1) | AU2012271068A1 (OSRAM) |
| BR (1) | BR112013031117A8 (OSRAM) |
| CA (1) | CA2837926A1 (OSRAM) |
| IL (1) | IL229658A0 (OSRAM) |
| RU (1) | RU2013154699A (OSRAM) |
| WO (1) | WO2012173808A1 (OSRAM) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7521481B2 (en) | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
| WO2014110277A1 (en) * | 2013-01-09 | 2014-07-17 | Elan Pharmaceuticals, Inc. | Methods of treating developmental and personality disorders |
| US11191735B2 (en) | 2015-03-13 | 2021-12-07 | Nutrition 21, Llc | Arginine silicate for periodontal disease |
| WO2017004226A1 (en) * | 2015-06-30 | 2017-01-05 | Jds Therepeutics, Llc | Arginine silicate inositol for improving cognitive function |
| WO2017029353A1 (en) * | 2015-08-20 | 2017-02-23 | Transition Therapeutics Ireland Limited | Treatment of behaviors in dementia patients |
| US20170135969A1 (en) | 2015-11-12 | 2017-05-18 | Jds Therapeutics, Llc | Topical arginine-silicate-inositol for wound healing |
| CN109890384A (zh) | 2016-09-01 | 2019-06-14 | Jds治疗有限公司 | 生物素镁组合物和使用方法 |
| MX2021005213A (es) | 2018-11-02 | 2021-09-08 | Nutrition 21 Llc | Composiciones que contienen complejos de silicato de arginina estabilizado con inositol y inositol para mejorar funciones cognitivas en jugadores de videojuegos. |
| MX2022006535A (es) * | 2019-12-02 | 2022-09-09 | Suven Life Sciences Ltd | Métodos para tratar síntomas de comportamiento y psicológicos en pacientes con demencia. |
| PL4069231T3 (pl) * | 2019-12-02 | 2025-09-08 | Suven Life Sciences Limited | Połączenia masupirdyny z donepezilem lub memantyną do leczenia obajwów behawioralnych i psychologicznych u pacjentów z demencją |
| IL294021A (en) | 2019-12-16 | 2022-08-01 | Nutrition 21 Llc | Methods of production of arginine-silicate complexes |
| JP2025530588A (ja) * | 2022-09-07 | 2025-09-16 | エアジェン ファーマ リミテッド | Ｓｃｙｌｌｏ－イノシトールとフラボンとの組み合わせ |
| CN115998724B (zh) * | 2023-03-28 | 2023-06-16 | 中国人民解放军军事科学院军事医学研究院 | 布洛芬在抗幻觉作用药物中的新用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7521481B2 (en) * | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
| IL156203A0 (en) * | 2003-05-29 | 2003-12-23 | Yissum Res Dev Co | Use of 2,2,3,3, tetramethylcyclopropane carboxylic acid derivatives for treating psychiatric disorders |
| DK2058390T3 (da) | 2003-10-14 | 2013-05-06 | Hokko Chem Ind Co | Fremgangsmåde til fremstilling af scyllo-inositol |
| ZA200807993B (en) * | 2006-03-09 | 2010-02-24 | Waratah Pharmaceuticals Inc | A cyclohexane polyalcohol formulation for treatment of disorders of protein aggregation |
| CA2644804A1 (en) * | 2006-03-09 | 2007-09-13 | Waratah Pharmaceuticals Inc. | A cyclohexane polyalcohol formulation for treatment of disorders of protein aggregation |
| EP2545023A4 (en) | 2010-02-15 | 2017-04-12 | Abbvie Inc. | Process for the preparation of scyllo-inositol |
| US20150306043A1 (en) * | 2012-09-28 | 2015-10-29 | Transition Therapeutics Ireland Limited | Combination treatments for bipolar disorders |
-
2012
- 2012-06-04 CA CA2837926A patent/CA2837926A1/en not_active Abandoned
- 2012-06-04 WO PCT/US2012/040789 patent/WO2012173808A1/en not_active Ceased
- 2012-06-04 RU RU2013154699/15A patent/RU2013154699A/ru not_active Application Discontinuation
- 2012-06-04 AU AU2012271068A patent/AU2012271068A1/en not_active Abandoned
- 2012-06-04 CN CN201280037339.8A patent/CN103906520A/zh active Pending
- 2012-06-04 KR KR1020147000006A patent/KR20140041670A/ko not_active Withdrawn
- 2012-06-04 JP JP2014513795A patent/JP2014515408A/ja active Pending
- 2012-06-04 BR BR112013031117A patent/BR112013031117A8/pt not_active IP Right Cessation
- 2012-06-04 EP EP12727719.2A patent/EP2714050A1/en not_active Withdrawn
- 2012-06-04 US US14/123,581 patent/US20140243422A1/en not_active Abandoned
-
2013
- 2013-11-27 IL IL229658A patent/IL229658A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112013031117A8 (pt) | 2018-08-14 |
| BR112013031117A2 (pt) | 2018-06-19 |
| RU2013154699A (ru) | 2015-07-20 |
| KR20140041670A (ko) | 2014-04-04 |
| CA2837926A1 (en) | 2012-12-20 |
| WO2012173808A1 (en) | 2012-12-20 |
| JP2014515408A (ja) | 2014-06-30 |
| EP2714050A1 (en) | 2014-04-09 |
| AU2012271068A1 (en) | 2013-12-19 |
| CN103906520A (zh) | 2014-07-02 |
| US20140243422A1 (en) | 2014-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL269852B (en) | Combined treatments and uses for the treatment of demyelination disorders | |
| IL229658A0 (en) | Scylo-inositol for the treatment of behavioral and psychiatric disorders | |
| IL229582A0 (en) | Antibodies against kir for the treatment of inflammatory disorders | |
| IL226401A0 (en) | Methods for treating disorders related to @fgfBA | |
| EP2552433A4 (en) | COMPOSITIONS AND METHODS OF TREATING SOMATOSENSORY DISEASES | |
| IL225239A0 (en) | Compounds for the treatment of acne and related diseases | |
| IL239368A0 (en) | Sparing–ppar thiazolidinediones and combinations for the treatment of neurodegenerative diseases of the nervous system | |
| IL233140A0 (en) | Device and methods for treating nervous disorders | |
| SG2014014724A (en) | METHODS FOR THE TREATMENT OF IL-1ß RELATED CONDITIONS | |
| IL232710A0 (en) | l-serine preparations, methods and uses for the treatment of neurodegenerative diseases and disorders | |
| IL233639A0 (en) | Preparations and methods for the treatment of diseases and liver disorders | |
| EP2707000A4 (en) | TREATMENT AND CONTROL OF CNS DISORDERS | |
| IL225896A0 (en) | Treatment of mecp-2 related disorders | |
| GB201207599D0 (en) | Transistor and the method of manufacture | |
| ZA201408060B (en) | Compositions and methods for the treatment of neurological disorders | |
| PT2691103T (pt) | Método para o tratamento de distúrbios da pele | |
| EP2739304A4 (en) | PARTICLES FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES | |
| ZA201408061B (en) | Compositions and methods for the treatment of neurological disorders | |
| ZA201408058B (en) | Compositions and methods for the treatment of epilepsy | |
| EP2734634A4 (en) | TREATMENT OF MIGRAINE AND RELATED DISEASES | |
| EP2999473A4 (en) | Treatment of neurological and other disorders | |
| GB201102366D0 (en) | Methods and reagents for the treatment of allergic disorders | |
| IL228973A (en) | Oxymetazoline for the treatment of rectal disorders | |
| GB201101183D0 (en) | Treatment of neurodegenerative disorders | |
| GB201303721D0 (en) | Compositions for treatment of sleep disorders |